kynurenine has been researched along with Brain Damage, Chronic in 1 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quist-Paulsen, E | 1 |
| Ormaasen, V | 1 |
| Kran, AB | 1 |
| Dunlop, O | 1 |
| Ueland, PM | 1 |
| Ueland, T | 1 |
| Eikeland, R | 1 |
| Aukrust, P | 1 |
| Nordenmark, TH | 1 |
1 other study available for kynurenine and Brain Damage, Chronic
| Article | Year |
|---|---|
Encephalitis and aseptic meningitis: short-term and long-term outcome, quality of life and neuropsychological functioning.
Topics: Adult; Aged; Biomarkers; Brain Damage, Chronic; Encephalitis; Female; Follow-Up Studies; Humans; Kyn | 2019 |